Efficacy and Safety of Topical 3% Minoxidil for Facial Hair Enhancement in Transgender Men: A Randomized, Double-Blind, Placebo-Controlled Trial
March 2026
in “
Journal of Dermatological Treatment
”
Studysummary In this randomized, double-blind, placebo-controlled trial, topical 3% minoxidil was found to significantly improve facial hair density and diameter, quality of life, and patient satisfaction in transgender men on stable gender-affirming hormone therapy, with minimal adverse events compared to placebo.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on tandfonline.com →